Black Diamond Therapeutics Inc
NASDAQ:BDTX

Watchlist Manager
Black Diamond Therapeutics Inc Logo
Black Diamond Therapeutics Inc
NASDAQ:BDTX
Watchlist
Price: 2.67 USD 4.71% Market Closed
Market Cap: 152.1m USD

Wall Street
Price Targets

BDTX Price Targets Summary
Black Diamond Therapeutics Inc

Wall Street analysts forecast BDTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BDTX is 9.44 USD with a low forecast of 6.06 USD and a high forecast of 13.65 USD.

Lowest
Price Target
6.06 USD
127% Upside
Average
Price Target
9.44 USD
253% Upside
Highest
Price Target
13.65 USD
411% Upside
Black Diamond Therapeutics Inc Competitors:
Price Targets
2480
Beijing Luzhu Biotechnology Co Ltd
34% Upside
4599
StemRIM Inc
176% Upside
XGN
Exagen Inc
154% Upside
RXRX
Recursion Pharmaceuticals Inc
62% Upside
2157
Lepu Biopharma Co Ltd
106% Upside
GOSS
Gossamer Bio Inc
180% Upside
NGNE
Neurogene Inc
200% Upside
002675
Yantai Dongcheng Biochemicals Co Ltd
29% Upside

Revenue
Forecast

Revenue Estimate
Black Diamond Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Black Diamond Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Black Diamond Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-41%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BDTX's stock price target?
Price Target
9.44 USD

According to Wall Street analysts, the average 1-year price target for BDTX is 9.44 USD with a low forecast of 6.06 USD and a high forecast of 13.65 USD.

Back to Top